Domov › Srdcové zlyhanie › Nebraska
Klinické štúdie Srdcové zlyhanie v štáte Nebraska
21 štúdií pre Srdcové zlyhanie hľadá účastníkov v zariadeniach v štáte Nebraska.
Mestá v štáte Nebraska
Oficiálny text štúdie (anglicky)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Lincoln
- Research Site, Lincoln
Prebieha náborFáza 3
Vek 18 až 130 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Be Well Clinical Studies, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Velocity Clinical Research-Lincoln-69943, Lincoln
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06424288A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Lincoln
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University of Nebraska Medical Center, Omaha
Prebieha náborFáza 3
Vek 18 až 85 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06736574Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- University of Nebraska Medical Center, Omaha
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07232030Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Bryan Heart, Lincoln
Prebieha náborFáza 3
Vek 18 až 99 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Norfolk
- Research Site, Omaha
Prebieha náborFáza 3
Vek 40 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10018, Omaha, NE, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Omaha, NE Investigative Site 10018, Omaha
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Nebraska Medical Center, Omaha
Prebieha nábor
Vek 18 až 100 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06310031Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Omaha
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- CHI Health Reseach Center, Omaha
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Omaha
Prebieha náborFáza 3
Vek 18 až 85 · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Bryan Heart, Lincoln
- Velocity Clinical Research Lincoln, Lincoln
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07567001Assessment of CCM in HF With Higher Ejection Fraction
- Bryan Heart, Lincoln
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT05064709Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Nebraska Medical Center, Omaha
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT06526195A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Velocity Clinical Research, Lincoln, Pioneer Heart Institute, Lincoln
Prebieha náborFáza 2
Vek 18 až 79 · Všetky pohlavia · Aktualizované 27. 5. 2026 · NCT06991257XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- University of Nebraska Medical Center, Omaha
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 3. 2026 · NCT06895070Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Creighton University Medical Center, Omaha
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2025 · NCT06964464AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Nebraska Heart Center, Lincoln
Prebieha náborObservačná štúdia
Vek 22 a viac · Všetky pohlavia · Aktualizované 26. 3. 2025 · NCT06378632Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.